Background: Down syndrome (DS) results from the presence and expression of three copies of the genes located on chromosome 21. Studies have shown that, in addition to overexpression of the Cystathionine β-synthase (CBS) gene, polymorphisms in genes involved in folate/homocysteine (Hcy) metabolism may also influence the concentrations of metabolites of this pathway. Aim: Investigate the association between Dihydrofolate reductase (DHFR) 19-base pair (bp) deletion and Serine hydroxymethyltransferase (SHMT) C1420T polymorphisms and serum folate and plasma Hcy and methylmalonic acid (MMA) concentrations in 85 individuals with DS. Methods: Molecular analysis of the DHFR 19-bp deletion and SHMT C1420T polymorphisms was performed by polymerase chain reaction (PCR) by difference in the size of fragments and real-time PCR allelic discrimination, respectively. Serum folate was quantified by chemiluminescence and plasma Hcy and MMA by liquid chromatography-tandem mass spectrometry. Results: Individuals with DHFR DD/SHMT TT genotypes presented increased folate concentrations (p=0.004) and the DHFR II/SHMT TT genotypes were associated with increased MMA concentrations (p=0.008). In addition, the MMA concentrations were negatively associated with age (p=0.04). Conclusion: There is an association between DHFR DD/SHMT TT and DHFR II/SHMT TT combined genotypes and folate and MMA concentrations in individuals with DS. © Copyright 2013, Mary Ann Liebert, Inc. 2013.174274277Biselli, J.M., Goloni-Bertollo, E.M., Haddad, R., The MTR A2756G polymorphism is associated with an increase of plasma homocysteine concentration in Brazilian individuals with Down syndrome (2008) Braz J Med Biol Res, 41, pp. 34-40Biselli, J.M., Zampieri, B.L., Goloni-Bertollo, E.M., Genetic polymorphisms modulate the folate metabolism of Brazilian individuals with Down syndrome (2012) Mol Biol Rep, 39, pp. 9277-9284Carvalho, V.M., Kok, F., Determination of serum methylmalonic acid by alkylative extraction and liquid chromatography coupled to tandem mass spectrometry (2008) Anal Biochem, 381, pp. 67-73Chen, J., Kyte, C., Valcin, M., Polymorphisms in the onecarbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study (2004) Int J Cancer, 110, pp. 617-620Coppus, A.W., Fekkes, D., Wma, V., Plasma amino acids and neopterin in healthy persons with Down syndrome (2007) J Neural Transm, 114, pp. 1041-1045De Andrade, C.R., Fukada, S.Y., Olivon, V.C., Alpha1Dadrenoceptor- induced relaxation on rat carotid artery is impared during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia (2006) Eur J Pharmacol, 543, pp. 83-91Dulucq, S., St-Onge, G., Gagné, V., DNA variants in the Dihydrofolate reductase gene and outcome in childhood ALL (2008) Blood, 111, pp. 3692-3700Fillon-Emery, N., Chango, A., Mircher, C., Homocysteine concentrations in adults with trisomy 21: Effect of B vitamins and genetic polymorphisms (2004) Am J Clin Nutr, 80, pp. 1551-1557Fowler, B., The folate cycle and disease in humans (2001) Kidney Int, 59, pp. 221-229Fu, T.F., Hunt, S., Schirch, V., Properties of human and rabbit cytosolic serine hydroxymethyltransferase are changed by single nucleotide polymorphic mutations (2005) Arch Biochem Biophys, 442, pp. 92-101Gellekink, H., Blom, H.J., Van Der Linden, I.J., Molecular genetic analysis of the human Dihydrofolate reductase gene: Relation with plasma total homocysteine, serum and red blood cell folate levels (2007) Eur J Hum Genet, 15, pp. 103-109Guéant, J.L., Anello, G., Bosco, P., Homocysteine and related genetic polymorphisms in Down syndrome IQ (2005) J Neurol Neurosurg Psychiatry, 76, pp. 706-709Haddad, R., Mendes, M.A., Höehr, N.F., Amino acid quantitation in aqueous matrices via trap and release membrane introduction mass spectrometry: Homocysteine in human plasma (2001) Analyst, 126, pp. 1212-1215Heil, S.G., Van Der Put Nmj, Waas, E.T., Is mutated Serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? (2001) Mol Genet Metab, 73, pp. 164-172Ishinohe, A., Kanaumi, T., Takashima, S., Cystathionine b-synthase is enriched in the brains of Down's patients (2005) Biochem Biophys Res Commun, 338, pp. 1547-1550Johnson, W.G., Stenroos, E.S., Spychala, J.R., New 19 bp deletion polymorphism in intron-1 of Dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy? (2004) Am J Med Genet, 124 A, pp. 339-345Kalmbach, R.D., Choumenkovitch, S.F., Troen, A.P., A 19-base pair deletion polymorphism in Dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate (2008) J Nutr, 138, pp. 2323-2327Licastro, F., Marocchi, A., Penco, S., Does Down syndrome support the homocysteine theory of atherogenesis? Experience in elderly subjects with trisomy 21 (2006) Arch Gerontol Geriatr, 43, pp. 381-387Lim, U., Peng, K., Shane, B., Polymorphisms in cytoplasmic Serine hydroxymethyltransferase and Methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men (2005) J Nutr, 135, pp. 1989-1994Marucci, G.H., Zampieri, B.L., Biselli, J.M., Polymorphism C1420T of Serine hydroxymethyltransferase gene on maternal risk for Down syndrome (2012) Mol Biol Rep, 39, pp. 2561-2566Meguid, N.A., Dardir, A.A., El-Sayed, E.M., Homocysteine and oxidative stress in Egyptian children with Down syndrome (2010) Clinic Biochem, 43, pp. 963-967Mendes, C.C., Biselli, J.M., Zampieri, B.L., 19-base pair deletion polymorphism of the dihydrofolate reductase (DHFR) gene: Maternal risk of Down syndrome and folate metabolism (2010) Sao Paulo Med J, 128, pp. 215-218Miller, S.A., Dykes, D.D., Polesky, H.F., A simple salting out procedure for extracting DNA from human nucleated cells (1988) Nucleic Acids Res, 16, p. 1215Pogribna, M., Melnyk, S., Pogribny, I., Homocysteine etabolism in children with Down syndrome: In vitro modulation (2001) Am J Hum Genet, 69, pp. 88-95Shin, J.H., Weitzdoerfer, R., Fountoulakis, M., Expression of cystathionine b-synthase, pyridoxal kinase, and ES1 protein homolog (mitochondrial precursor) in fetal Down syndrome brain (2004) Neurochem Int, 45, pp. 73-79Skibola, C.F., Forrest, M.S., Coppedé, F., Polymorphisms and haplotypes in folate-metabolizing genes and risk of non- Hodgkin lymphoma (2004) Blood, 104, pp. 2155-2162Stanisiawska-Sachadyn, A., Brown, K.S., Mitchell, L.E., An insertion/deletion polymorphism of the Dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women (2008) Hum Genet, 123, pp. 289-295Xu, X., Gammon, M.D., Wetmur, J.G., A functional 19- base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users (2007) Am J Clin Nutr, 85, pp. 1098-1102